The latest closing stock price for Summit Therapeutics as of June 06, 2025 is 20.59.
An investor who bought $1,000 worth of Summit Therapeutics stock at the IPO in 2015 would have $1,080 today, roughly 1 times their original investment - a 7.60% compound annual growth rate over 10 years.
The all-time high Summit Therapeutics stock closing price was 36.70 on April 24, 2025.
The Summit Therapeutics 52-week high stock price is 36.91, which is 79.3% above the current share price.
The Summit Therapeutics 52-week low stock price is 6.78, which is 67.1% below the current share price.
The average Summit Therapeutics stock price for the last 52 weeks is 18.29.
An investor who bought $1,000 worth of Summit Therapeutics stock at the IPO in 2015 would have $1,080 today, roughly 1 times their original investment - a 7.60% compound annual growth rate over 10 years.
The all-time high Summit Therapeutics stock closing price was 36.70 on April 24, 2025.
The Summit Therapeutics 52-week high stock price is 36.91, which is 79.3% above the current share price.
The Summit Therapeutics 52-week low stock price is 6.78, which is 67.1% below the current share price.
The average Summit Therapeutics stock price for the last 52 weeks is 18.29.